The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz
- 1 June 2011
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 90 (1) , 151-156
Abstract
Many antiretroviral (ARV) drugs have large blood plasma‐to‐seminal plasma (BP/SP) concentration ratios. Concern exists that these drugs do not adequately penetrate the male genital tract (MGT), resul...Keywords
This publication has 18 references indexed in Scilit:
- Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-Negative MenThe Journal of Infectious Diseases, 2011
- A highly sensitive ultra performance liquid chromatography–tandem mass spectrometric (UPLC–MS/MS) technique for quantitation of protein free and bound efavirenz (EFV) in human seminal and blood plasmaJournal of Chromatography B, 2010
- The importance of plasma protein binding in drug discoveryExpert Opinion on Drug Discovery, 2007
- A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculateBritish Journal of Clinical Pharmacology, 2006
- Binding of Anti‐HIV Drugs to Human Serum AlbuminIUBMB Life, 2004
- Roundtable Report: Importance of Antiretroviral Drug Concentrations in Sanctuary Sites and Viral ReservoirsAIDS Research and Human Retroviruses, 2003
- Pharmacokinetic and Pharmacodynamic Investigation of Efavirenz in the Semen and Blood of Human Immunodeficiency Virus Type 1–Infected MenThe Journal of Infectious Diseases, 2002
- Antiretroviral drug concentrations in semen of HIV-1 infected menSexually Transmitted Infections, 2001
- Sexual Transmission of HIVNew England Journal of Medicine, 1997
- Potential Effect of the Plasma Proteins on Drug DistributionNature, 1965